Iris Acquisition Corp
Status: Closed Deal
U=S+W/4
W=S@11.5
IPO Proceeds, $M | $276.00M |
---|---|
IPO Date | Mar 5, 2021 |
CEO | Sumit Mehta |
Left Lead | Cantor Fitzgerald |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 + 6 + 6 + 6 + 3 + 3 |
IPO Sector | General ▶ |
IPO Geography | Global |
Target Company | Liminatus Pharma |
Deal Announced | Nov 30, 2022 |
Deal Size, $M | $175.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings |
www.sec.gov |
Approval Vote | Mar 4, 2025 |
Amendment Vote | Dec 20, 2024 |
Closing Date | Apr 30, 2025 |
Formerly IRAA
LIMN
LIMNW
Price | $7.01 |
---|---|
Last closing price | $5.22 |
H/L, today | $5.82 / $7.45 |
Volume, today | 822,339 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.